SOURCE: TomoTherapy

TomoTherapy

September 02, 2009 16:15 ET

TomoTherapy to Present at Three Upcoming Investment Conferences

Company Featured at Citi Radiation Oncology Seminar on Sept. 9, Baird Health Care Conference on Sept. 10, and Thomas Weisel Partners Health Care Conference on Sept. 11

MADISON, WI--(Marketwire - September 2, 2009) - TomoTherapy Incorporated (NASDAQ: TOMO) today announced that company management will participate in three investment community conferences in September.

On Wednesday, Sept. 9, 2009, Dr. Fred Robertson, CEO, and Thomas Powell, CFO, will attend Citigroup Investment Research's 3rd Annual Radiation Oncology Seminar. Robertson will participate in two panel discussions: on proton therapy, from 10:45 to 11:45 a.m. ET; and on radiosurgery and radiation therapy from 2:45 to 3:45 p.m. ET. The conference takes place at the Citigroup Executive Conference Center in New York City, N.Y.

Robertson and Powell will also present at the Robert W. Baird & Co. 2009 Health Care Conference on Thursday, Sept. 10, 2009, at 9:00 a.m. ET. The conference is being held at the Four Seasons Hotel in New York City, N.Y.

On Friday, Sept. 11, 2009, Robertson and Powell will present at the Thomas Weisel Partners Healthcare Conference 2009 at 11:30 a.m. ET. The conference takes place at the Four Seasons Hotel in Boston, Mass.

Live Webcasts of the Baird and Weisel presentations will be available on the investor relations page of TomoTherapy.com. For those who are unable to listen to the live presentations, archives of the Webcasts will be available on the company's site for 30 days following the presentation. The Citigroup panel discussions are not being Webcast.

About TomoTherapy Incorporated

TomoTherapy Incorporated has developed, markets and sells the TomoTherapy® Hi·Art® treatment system, an advanced radiation therapy system for the treatment of a wide variety of cancers. The Hi·Art treatment system combines integrated CT imaging with conformal radiation therapy to deliver sophisticated radiation treatments with speed and precision while reducing radiation exposure to surrounding healthy tissue. The company's stock is traded on the NASDAQ Global Select Market under the symbol TOMO. To learn more about TomoTherapy, please visit TomoTherapy.com.

©2009 TomoTherapy Incorporated. All rights reserved. TomoTherapy, Tomo, the TomoTherapy logo and Hi·Art are among trademarks, service marks or registered trademarks of TomoTherapy Incorporated in the United States and other countries.

Contact Information

  • Investor Contact:
    Thomas E. Powell
    Chief Financial Officer
    608.824.2800
    Email Contact

    Media Contacts:
    Kevin O'Malley
    Manager, Corporate Communications
    608.824.3384
    Email Contact

    Susan Lehman
    Rockpoint Public Relations
    510.832.6006
    Email Contact